Clinical Trial Update: High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial results for high-dose interferon alfa-2b in stage II or stage III melanoma have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon alfa-2b (Intron A) (interferon alfa-2b)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Melanoma (Skin) | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2016-05-04